VN1R69P

Across TCGA pan-cancer cohorts, VN1R69P RNA is linked to patient survival in 6 of 34 cancer types, making it the most broadly survival-associated VN1R69P data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher VN1R69P RNA is associated with better overall survival. In most high-consensus cancer types, elevated VN1R69P expression acts as an unfavorable survival marker, although some lineages such as LUAD show a favorable association.

LUAD, THCA, and LUSC are the cancer types where VN1R69P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	II,III,IV	1.000	0.217	.014	27	view →
THCA	DFS	Tertile	All	0.736	0.901	.002	18	view →
LUSC	DFS	Tertile	II,III,IV	0.321	0.616	.044	18	view →
LGG	OS	Tertile	All	0.178	0.464	.015	12	view →
SARC	OS	Tertile	All	0.511	0.860	.020	9	view →
OV	OS	Tertile	II,III,IV	0.719	0.853	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

VN1R69P–LUAD (OS)

Open the LUAD breakdown →